via Phys.org
University of Otago researchers have discovered new ways to treat antibiotic-resistant strains of tuberculosis (TB), opening the door to new approaches for tackling the disease that kills about 4,000 people a day.
Led by PhD candidate Natalie Waller and Senior Author Dr Matthew McNeil, of the Department of Microbiology and Immunology, researchers were able to identify antibiotics that could rapidly kill drug resistant strains of TB and when combined could stop drug resistance from occurring altogether.
TB is a major global cause of infectious disease morbidity and mortality, second only to COVID-19 and is one of the hardest infections to treat. Ten million people develop the disease every year and it kills about 4,000 people a day. About 300 cases of TB are diagnosed in New Zealand each year.
Adding to the challenge, is that drug-resistant strains of the disease – that are very hard to treat and have limited treatment options – are spreading at an “alarming rate”.
“We need not only new drugs, but better drug combinations that can improve treatment success and prevent the further spread of antibiotic resistance,” Dr McNeil says.
Typically, antibiotic resistance leads to reduced sensitivity, but in some cases becoming resistant to one antibiotic can make a pathogen more sensitive to other completely unrelated antibiotics, he says. However, this phenomenon – collateral sensitivity – has largely been unexplored in TB, until now.
“It is very hardy, resilient and hard to study in the lab because it is a dangerous pathogen that grows extremely slowly.
“To overcome this, our study used a weakened non-virulent strain of Mycobacterium tuberculosis that cannot cause disease or survive outside of the lab to generate strains that were resistant to different antibiotics,” he says.
Researchers then determined if the drug-resistant strains of the bacterium had either increased or reduced sensitivity to other antibiotics.
“We wanted the results of our work to have the greatest chance for clinical impact. For this reason, our study placed an emphasis on drugs that are either clinically approved or in pre-clinical development,” Dr McNeil says.
“Excitingly this work identified a number of instances in which a particular drug-resistant strain was more sensitive to antibiotics that targeted a completely unrelated pathway. We then showed we could use these specific drugs to rapidly kill drug resistant strains as well as design unique drug combinations that prevented the emergence of drug resistance.
“Put simply, this work demonstrates that drug resistant strains of M. tuberculosis have unique weaknesses, that if we can identify them, can be targeted to greatly reduce treatment times and prevent the emergence of drug resistance.”
Dr McNeil says work will now need to focus on further extending these findings into in animal studies.
“There is still work to do, but this is certainly a significant step in the fight again anti-microbial resistance.”
Original Article: Significant step in fight against drug resistance in TB
More from: University of Otago
The Latest Updates from Bing News
Go deeper with Bing News on:
Antibiotic-resistant strains of tuberculosis
- Immune-enhancing therapies to treat TB: Study
Experts are developing revolutionary immune-enhancing medicines known as host-directed therapies, which employ the body's immune system to target TB, to tackle even drug -resistant strains of the ...
- Enhancing Immunity to Combat Tuberculosis
Researchers explore host-directed therapies, harnessing the body's immune system to combat tuberculosis, including drug-resistant strains.
- Significant challenge posed by drug-resistant TB strains to efficacy of treatment, control measures: Study
The findings highlighted resistance not only to rifampicin, a drug used to manage and treat diverse mycobacterial infections, and isoniazid, an antibiotic indicated in the first-line treatment of ...
- Absence of full drug-susceptibility data for TB patients can result in amplifying resistance: study
Study by HaystackAnalytics & Dr. D.Y. Patil Medical College reveals high prevalence of pre-XDR-TB in MDR-TB cases in India.
- Doctors named diseases that are hard to treat with antibiotics
The effectiveness of treating tuberculosis with so-called multidrug-resistant strains is less than 60%, and such treatment requires significantly more time and resources. The spread of antibiotic ...
Go deeper with Bing News on:
Tuberculosis
- Saltz Mongeluzzi Files Product Liability Suit Alleging Tuberculosis Contracted From FiberCel Bone Graft Implant, Expects Dozens More
This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in federal and state courts. Law.com Radar now offers state court coverage nationwide. Sign up today ...
- Tuberculosis Claims 108 Lives in Mizoram in 2023
Health officials in Mizoram reported on Wednesday that a total of 108 individuals succumbed to tuberculosis (TB) in the state last year. Authorities disclosed that blood samples from 17,432 ...
- African-born bioengineer at UCLA develops new tuberculosis test
Some 1.3 million people died from tuberculosis in 2022. The disease is fully treatable but relies on timely diagnosis. Mireille Kamariza, a molecular bioengineer from UCLA, has developed a test that ...
- With pandemic over, deadliest infectious disease in world is still tuberculosis
Just a short time after “Gone With the Wind star” Vivien Leigh appeared at Atlanta’s Loews Grand Theatre for the 1939 premiere of the legendary film, the British actress caught tuberculosis on a trip ...
- Japan's Princess Kiko tours historic Tokyo suburban tuberculosis treatment hub
Crown Princess Kiko, the wife of Crown Prince Akishino (Fumihito), on April 30 visited the suburban Tokyo city of Kiyose, which has historica ...